Clostridium Diagnostics 2017 Global Market Expected to Grow at CAGR of 14.71% and Forecast to 2021

New York, NY -- (SBWire) -- 09/04/2017 --Clostridium Diagnostics Market 2017

Executive Summary
Clostridium is a gram-positive bacteria that belongs to the Firmicutes phylum. There are multiple species of Clostridium — Clostridium botulinum, Clostridium difficile, Clostridium perfringens, Clostridium tetani, and Clostridium sordellii, which are responsible for numerous infections. Clostridium tetani is responsible for tetanus, Clostridium botulinum causes botulism, Clostridium perfringes leads to gas gangrene, Clostridium sortellii causes pneumonia, endocarditis, arthritis, peritonitis, and myonecrosis, and Clostridium difficile is responsible for diarrhea.

The analysts forecast the global clostridium diagnostics market to grow at a CAGR of 14.71% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global clostridium diagnostics market for 2017-2021. To calculate the market size, the report considers the sales/volume/value.

The market is divided into the following segments based on geography:
- Americas
- APAC
- EMEA

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/1651712-global-clostridium-diagnostics-market-2017-2021

The report, Global Clostridium Diagnostics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
- Abbott
- Beckman Coulter
- Olympus
- Siemens Healthineers
- F. Hoffmann-La Roche

Other prominent vendors
- BD
- bioMerieux
- Chrono-log Corporation
- Corgenix
- Diazyme Laboratories
- FUJIREBIO DIAGNOSTICS
- Hologic
- QIAGEN
- Sysmex Corporation
- Thermo Fisher Scientific

Market driver
- Rising prevalence of Clostridium-related diseases
- For a full, detailed list, view our report

Market challenge
- High cost of molecular diagnostics over immunoassays
- For a full, detailed list, view our report

Market trend
- Technological advancements
- For a full, detailed list, view our report

Complete Report Details @ https://www.wiseguyreports.com/reports/1651712-global-clostridium-diagnostics-market-2017-2021

Table of Contents – Key Points Analysis

PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
- Market outline

PART 05: Market landscape
- Market overview
- Market size and forecast
- Five forces analysis

PART 06: Market segmentation by technology
- Immunoassays
- Molecular diagnostics

PART 07: Market segmentation by product
- Clostridium difficile
- Clostridium perfringens
- Clostridium botulinum
- Clostridium tetani
- Clostridium sordellii

PART 08: Market segmentation by end-user
- Hospitals
- Independent laboratories
- Physicians' clinics

PART 09: Geographical segmentation
- Market overview
- Americas
- EMEA
- APAC

PART 10: Decision framework
PART 11: Drivers and challenges
- Market drivers
- Market challenges

PART 12: Market trends
- Technological advancements
- Increasing focus on reducing nosocomial infections
- Growing popularity of portable POCT products
..…..Continued

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=1651712